Single-Staged arm basilic vein transposition for arteriovenous fistula surgery - clinical pearls and outcomes

Abstract

Background: Arm basilic vein transposition (aBVT) is a well-established arteriovenous (AV) access modality for the end-stage renal disease (ESRD) to ensure hemodialysis. Purpose: The purpose was to discuss the clinical pearls and evaluate the outcomes of single-stage aBVT procedure. Methods: This was a retrospective case series Results: Twenty-four patients with ESRD underwent single-stage aBVT as an AV access procedure. A majority (58.33%) of patients aged between 45 and 65 years. Diabetic nephropathy was the most common cause of renal failure. The patency achieved was 83.33% at the end of a 12-month follow-up period. Conclusion: The single-stage procedure is a safe, efficient, and cost-effective option for these patients, especially in the developing regions of the world. Here, we elaborate on the simple tips and pointers to ensure an effective single-stage procedure to minimize complications of kinks, thrombosis, or early failure and achieve faster time to cannulation and a longer cannulation length.